Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HTR2A | P28223 | 4/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL31411316 | 0.90 | ACHE (0.35) | ALDH1A1KDM4ECYP3A4MEN1KMT2A | |
| SCHEMBL31411305 | 0.88 | HTR1A (0.43) | ALDH1A1KDM4EHTR1AHTR2AHTR2C | |
| SCHEMBL31411340 | 0.84 | HTR1A (0.33) | ALDH1A1KDM4EHTR1AHTR2A | |
| SCHEMBL31411299 | 0.80 | HTR1A (0.46) | ALDH1A1KDM4ECYP1A2CYP3A4CYP2D6 | |
| Fumaric Acid SCHEMBL31411436 | 0.79 | NPSR1 (0.37) | ALDH1A1KDM4ECYP3A4BLMPMP22 | |
| SCHEMBL31411359 | 0.78 | HTR2A (0.36) | HTR1AHTR2ADRD2HTR2C | |
| SCHEMBL25436799 | 0.77 | HTR1A (0.53) | ALDH1A1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL31411272 | 0.75 | HTR2A (0.36) | ALDH1A1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL31411358 | 0.74 | HTR1A (0.47) | ALDH1A1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL31411322 | 0.74 | HTR2A (0.39) | HTR2ADRD2HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735425-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2026-05-06 | — | — | EP | disclosed |
| US-20250353818-A1 | Compounds | Psylo Pty Ltd (AU) | 2025-11-20 | — | — | US | disclosed |
| US-12428380-B2 | Compounds | Psylo Pty Ltd (AU) | 2025-09-30 | — | — | US | disclosed |
| US-20250214943-A1 | Compounds | Psylo Pty Ltd (AU) | 2025-07-03 | — | — | US | disclosed |
| WO-2025000053-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-01-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214943-A1 | Compounds | NLN, SLC18A2, PYGB | ALDH1A1 981/4885KDM4E 3243/4885CYP1A2 442/4885 |
| US-12428380-B2 | Compounds | NLN, SLC18A2, PYGB | ALDH1A1 981/4885KDM4E 3243/4885CYP1A2 442/4885 |
| US-20250353818-A1 | Compounds | NLN, SLC18A2, PYGB | ALDH1A1 981/4885KDM4E 3243/4885CYP1A2 442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.